Total Payments
$2,920
2024 Payments
$93.38
Companies
39
Transactions
204
Medicare Patients
2,973
Medicare Billing
$599,714
Payment Breakdown by Category
Food & Beverage$2,746 (94.0%)
Consulting$150.00 (5.1%)
Education$24.84 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,746 | 200 | 94.0% |
| Consulting Fee | $150.00 | 1 | 5.1% |
| Education | $24.84 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $363.46 | 42 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $342.78 | 22 | $0 (2024) |
| PFIZER INC. | $329.87 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $297.86 | 22 | $0 (2020) |
| Merck Sharp & Dohme LLC | $196.64 | 8 | $0 (2023) |
| Alkermes, Inc. | $150.00 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $147.79 | 7 | $0 (2022) |
| Novo Nordisk Inc | $133.85 | 9 | $0 (2020) |
| ABBVIE INC. | $93.55 | 5 | $0 (2023) |
| Lilly USA, LLC | $86.34 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.38 | 5 | AstraZeneca Pharmaceuticals LP ($30.80) |
| 2023 | $47.23 | 3 | ABBVIE INC. ($18.38) |
| 2022 | $182.56 | 11 | Merck Sharp & Dohme LLC ($34.48) |
| 2021 | $212.56 | 14 | AbbVie Inc. ($55.36) |
| 2020 | $367.62 | 34 | Allergan, Inc. ($179.59) |
| 2019 | $526.55 | 32 | Novartis Pharmaceuticals Corporation ($116.05) |
| 2018 | $492.33 | 40 | Allergan Inc. ($123.86) |
| 2017 | $998.11 | 65 | Alkermes, Inc. ($150.00) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Diabetes | ||||||
| 03/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/03/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Gastroenterology | ||||||
| 04/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), VERQUVO, STEGLUJAN | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/19/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Neuroscience | ||||||
| 07/07/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $11.80 | General |
| Category: Cardiovascular | ||||||
| 06/15/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/15/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/09/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Cardiovascular | ||||||
| 04/28/2022 | Medtronic, Inc. | MICROSTREAM (Device) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Capnography Monitoring | ||||||
| 04/12/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/17/2022 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: non-opioid analgesic | ||||||
| 03/01/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/23/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Diabetes Care | ||||||
| 06/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $11.30 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 232 | 648 | $100,059 | $55,189 |
| 2022 | 10 | 436 | 1,017 | $154,352 | $88,460 |
| 2021 | 16 | 1,012 | 2,583 | $378,236 | $202,418 |
| 2020 | 19 | 1,293 | 3,587 | $503,193 | $253,646 |
Total Patients
2,973
Total Services
7,835
Medicare Billing
$599,714
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 248 | $45,916 | $25,588 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 303 | $38,451 | $22,229 | 57.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 41 | $10,373 | $5,195 | 50.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 43 | $4,894 | $1,975 | 40.3% |
| 90471 | Administration of vaccine | Office | 2023 | 12 | 13 | $424.87 | $202.32 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 353 | $61,775 | $35,030 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 199 | $21,890 | $14,670 | 67.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 85 | 91 | $22,993 | $14,182 | 61.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 144 | $15,820 | $8,508 | 53.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 36 | 36 | $7,776 | $4,857 | 62.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 34 | $6,477 | $3,353 | 51.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 24 | 101 | $8,556 | $3,272 | 38.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 32 | $5,920 | $2,739 | 46.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 14 | $2,100 | $1,234 | 58.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 13 | $1,045 | $615.27 | 58.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 136 | 631 | $110,425 | $67,540 | 61.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 174 | 722 | $82,240 | $42,766 | 52.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 105 | 109 | $27,889 | $17,481 | 62.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 87 | 172 | $31,837 | $14,772 | 46.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 167 | $18,370 | $12,247 | 66.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 80 | 94 | $18,743 | $10,711 | 57.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 73 | 307 | $26,059 | $9,858 | 37.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 86 | 97 | $15,655 | $8,574 | 54.8% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 44 | 101 | $19,696 | $6,055 | 30.7% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 36 | 41 | $10,183 | $4,605 | 45.2% |
About Dr. John Moskaitis, MD
Dr. John Moskaitis, MD is a Internal Medicine healthcare provider based in Fairless Hills, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316042591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Moskaitis, MD has received a total of $2,920 in payments from pharmaceutical and medical device companies, with $93.38 received in 2024. These payments were reported across 204 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($2,746).
As a Medicare-enrolled provider, Moskaitis has provided services to 2,973 Medicare beneficiaries, totaling 7,835 services with total Medicare billing of $599,714. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fairless Hills, PA
- Active Since 09/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316042591
Products in Payments
- FARXIGA (Drug) $315.06
- ENTRESTO (Drug) $297.86
- VRAYLAR (Drug) $228.88
- UBRELVY (Drug) $143.29
- CHANTIX (Drug) $127.48
- ZERBAXA (Drug) $95.54
- TRELEGY ELLIPTA (Drug) $68.69
- BYSTOLIC (Drug) $67.40
- LYRICA (Drug) $67.17
- ELIQUIS (Drug) $62.06
- UTIBRON (Drug) $61.91
- SUBSYS (Drug) $57.14
- JANUVIA (Drug) $51.78
- XIFAXAN (Drug) $49.94
- Tresiba (Drug) $49.72
- TRULICITY (Drug) $45.74
- ANORO (Drug) $45.19
- Ozempic (Drug) $42.86
- OXYCONTIN (Drug) $35.63
- REXULTI (Drug) $34.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.